Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 257: Biogen’s $2B Investment in North Carolina’s RTP with Nicole Murphy
Hospice Insights Podcast - If Only I Knew… Avoiding the Most Common Mistakes with the 855
H-1B Enforcement Tightened, Fertility Benefits Expanded, Gender Identity Protection Setback - #WorkforceWednesday® - Employment Law This Week®
Workplace Mental Health: Strategies for Stress and Anxiety Relief
Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 256: AI, Advocacy & Clinical Trials with Sophia McLeod of ACRO
Current Tailwinds in Women’s Health - What Do They Mean for Your Business? – Diagnosing Health Care Video Podcast
Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 255: Private Equity Essentials for Life Sciences Organizations and Startups
The IP Future: Intellectual Property Challenges in AI Health Care Contracts – The Good Bot: Artificial Intelligence, Health Care, and the Law
Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 254: Responsible AI in Healthcare with Dr. Justin Collier of Lenovo
What's New with the False Claims Act?
Hospice Insights Podcast - Making Palliative Care a Win-Win-Win: A Conversation with Dr. Bethany Snider, Chief Medical Officer, Hosparus Health
Exploring Long-Term Home Care Solutions with Albert Eshoo & Joyce Barocas
Employee Benefits and Executive Compensation Preparing for 2026 – Top Five Health and Welfare Updates — Troutman Pepper Podcast
AGG Talks: Government Insight for Life Sciences Leaders - Episode 2: DOJ’s Shifting Enforcement: CPB Disbanding, Counterfeit Drug Focus, and Gender-Affirming Care Investigations
Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 253: The Rise of Ambulatory Surgery Centers with Mark Wainner of ASCA
FTC Backs Off Non-Compete Ban, Warns Health Care Employers - #WorkforceWednesday® - Employment Law This Week®
The Latest on Value Based Care
Navigating Women's Health with Rachel Welch
Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 252: Navigating Policy and Technology Shifts in MedTech with Bobby Patrick of AdvaMed
Hospice Insights Podcast - Let’s Face (to Face) It: Important Changes to Hospice Face-to-Face Attestation Requirements and Other Tidbits from the 2026 Hospice Final Rule
CMS has a skin substitute problem. Skin substitutes are wound coverings that are used for burns, trauma, or chronic conditions like wounds associated with diabetes, leg ulcers, etc. According to the National Institutes...more
The Polsinelli | TrBK Distress Indices are prepared and published quarterly. The indices are contrarian measures of economic performance, and are intended to reflect the level of economic distress in the U.S. economy by...more
Key Takeaways - CMS and DOJ activity related to the Stark Law has been notably quiet in recent years, with no material rule updates since 2023 and limited enforcement actions. This slowdown has left many providers...more
On December 2, 2025, the United States Supreme Court will hear oral argument in First Choice Women's Resource Centers, Inc. v. Platkin, a case with significant implications for nonprofit donor privacy, First Amendment rights,...more
When most people think about Medicaid, they focus on the financial component — income and asset limits that determine eligibility. For some Medicaid programs, however, the focus needs to be on both financial and clinical...more
On November 9, 2025, the Senate voted to proceed to consideration of a continuing resolution (CR) through January 30, 2026, that includes three full-year appropriations bills for fiscal year (FY) 2026 and additional...more
In the United States, medical device regulation and intellectual property (IP) protection are governed by complex statutory and regulatory frameworks that are distinct from—but closely related to, and in some cases...more
This episode, hosts Heather and Matthew sit down with Nicole Murphy, Executive Vice President and Head of Pharmaceutical Operations and Technology at Biogen. Nicole shares why Biogen is growing in North Carolina with a $2...more
Through our Venable FDA Pulse series, we provide insight into key developments within the Food and Drug Administration (FDA or the Agency), emerging trends, enforcement activity, and other topics impacting stakeholders. ...more
The Alabama Supreme Court issued its weekly release list on Friday, November 7, which included one opinion of interest to the Alabama business community...more
Each week while Congress is in session, our Policy team delivers a key update to highlight a topical benefits, health, or retirement news item from the Hill, such as a newly introduced bill, a summary of a committee hearing,...more
The Trump Administration recently announced a multi-pronged deal with Eli Lilly and Novo Nordisk aimed at lowering the cost of GLP-1 medications used for weight loss and diabetes. While many details remain in flux, the...more
“By streamlining the biosimilar development process and helping advance interchangeability, we can achieve massive cost reductions for advanced treatments for cancer, autoimmune diseases, and rare disorders affecting millions...more
In this episode of Health Law Diagnosed, Of Counsel Bridgette Keller welcomes Mintz Members Daniel Cody and Deborah Daccord to unpack the latest legislative developments reshaping health care transactions in California,...more
For years, the conversation around health insurer consolidation and vertical integration has simmered through antitrust inquiries, oversight hearings, and policy papers. The Patients Over Profit Act (the “POP Act”),...more
Benefit from compliance education and networking in your area! HCCA’s Regional Healthcare Compliance Conferences offer convenient, local compliance education in a variety of locations across the country, and feature...more
Key Takeaways: Major Financial and Operational Impact: On Nov. 5, 2025, CMS finalized a rule that fundamentally changes Medicare payment methodology for a broad range of skin substitute products used for wound care....more
42 CFR Part 2: What Changed, Why It Matters, and What to Do Now - On November, 7, 2025, I spoke to the Massachusetts Health Information Management Association about the federal government’s sweeping updates to 42 CFR Part...more
Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more
In Summer 2025, the U.S. Court of Appeals for the Sixth Circuit issued a strongly worded decision in In Re: FirstEnergy Corporation (No. 24-3654)—confirming the core concept that internal investigations conducted by counsel...more
Our FDA: Drug & Device Team examines the FDA’s new draft guidance that allows biosimilar developers to rely more on analytical and pharmacokinetic data, reducing the need for costly and time-consuming comparative efficacy...more
Health care fraud, public corruption and other types of fraud have emerged as apparent top white collar enforcement priorities of the United States Attorney’s Office for the Northern District of Illinois under the leadership...more
Government shutdown breaks record. As the shutdown passed the 35-day record, negotiations to reopen the government continued....more
This issue of McDermott Will & Schulte’s Healthcare Regulatory Check-Up highlights regulatory activity for September 2025, including an update on the Centers for Medicare & Medicaid Services (CMS) Rural Health Transformation...more